Stroke: Specialized Ambulances Improved Treatment Time, Costs May Be Prohibitive

Priv.-Doz. Dr. med. Dr. phil. Martin Ebinger Oberarzt der Klinik und Hochschulambulanz für Neurologie am Campus Charité Mitte Center for Stroke Research Berlin (CSB) Charité - Universitätsmedizin Berlin | CCM Charitéplatz 1 | 10117 Berlin | GermanyMedicalResearch.com Interview with:
Priv.-Doz. Dr. med. Dr. phil. Martin Ebinger
Oberarzt der Klinik und Hochschulambulanz
für Neurologie am Campus Charité Mitte
Center for Stroke Research Berlin (CSB)
Charité – Universitätsmedizin Berlin | CCM
Charitéplatz 1 | 10117 Berlin | Germany

MedicalResearch.com: What are the main findings of the study?

Dr. Ebinger: The main findings of our study was a significant time reduction during randomized weeks with prehospital thrombolysis compared to control weeks with regular care.

MedicalResearch.com: What should clinicians and patients take away from your report?

Dr. Ebinger: Prehospital thrombolysis increased thrombolysis rate to 33%, reduced time from alarm-to-treatment and was not associated with increased risks.

MedicalResearch.com: What recommendations do you have for future research as a result of this study?

Dr. Ebinger: Researchers in emergency medicine may rethink the opportunities to place certain time critical interventions into the prehospital phase.
Citation:

Effect of the Use of Ambulance-Based Thrombolysis on Time to Thrombolysis in Acute Ischemic Stroke: A Randomized Clinical Trial
Martin Ebinger MD, Benjamin Winter MD, Matthias Wendt MD, Joachim E. Weber MD, Carolin Waldschmidt MD, Michal Rozanski MD, Alexander Kunz MD, Peter Koch MD, Philipp A. Kellner MD, Daniel Gierhake MD, Kersten Villringer MD, Jochen B. Fiebach MD, Ulrike Grittner PhD, Andreas Hartmann MD, Bruno-Marcel Mackert MD, Matthias Endres MD, Heinrich J. Audebert MD

JAMA. 2014;311(16):1622-1631. doi:10.1001/jama.2014.2

 

Please follow and like us: